New Delhi, Aug 16 (IANS) Mpox vaccine procurement for at-risk populations across Africa is crucial to contain the deadly outbreak and save lives, according to a report on Friday. The report by GlobalData, a data and analytics company, noted that while Mpox vaccines played an important role in containing the 2022 mpox outbreak in high-income nations, “none are currently widely available in Africa”. Bavarian Nordic’s MVA-BN vaccine (Jynneos/Imvanex) — approved in the US, Europe, and Canada — is the leading mpox vaccine worldwide. In addition, KM Biologics’ LC16 vaccine is available in Japan and Emergent BioSolutions’ ACAM2000 is also under regulatory review for mpox in the US. Fiona Chisholm,
Hence then, the article about mpox vax procurement in africa key to contain outbreak report was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Mpox vax procurement in Africa key to contain outbreak: Report )